Drug details
Xywav (calcium, magnesium, potassium, and sodium oxybates oral solution)
type of CNS Depressants
Xywav (calcium, magnesium, potassium, and sodium oxybates) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
This drug may have the following side effects:
- nausea,
- diarrhea,
- dizziness,
- headache,
- vomiting
- anxiety,
- weight loss
- increased sweating,
- decreased appetite,
- abnormal sleep behaviors (parasomnia),
- bed wetting (in children), and
The following drugs are related to Xywav, either as a replacement or used together:
- Lumryz (sodium oxybate for extended-release oral suspension)
- Ritalin (methylphenidate hcl)
- Ritalin LA (methylphenidate hydrochloride extended-release capsules)
- Provigil (modafinil)
- Wakix (pitolisant tablets)
- Xyrem (sodium oxybate)
- Sunosi (solriamfetol tablets)